See All Slides - tctmd.com

Slides

Presentation TCT 2012

Fiberoptic Cardioscopy for Use in Epicardial Injection of Cell Suspensions and Biomaterials

Presenter: Henricus Duckers

October 22, 2012

Presentation TCT 2012

Stent Thrombosis Meta-analysis

Presenter: Tullio Palmerini

October 22, 2012

Presentation TCT 2012

Aortic Stenosis Diagnostic and Therapeutic Clinical Pearls: A Selective View from the Guidelines (and Beyond): What Is KNOWN!

Presenter: Blase Carabello

October 22, 2012

Presentation TCT 2012

Step 3: Intellectual Property

Presenter: Casey McGlynn

October 22, 2012

Presentation TCT 2012

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Presenter: Giuseppe De Luca

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

Presentation TCT 2012

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Presenter: Alessandro Bortone

October 22, 2012

Presentation TCT 2012

Case Presentation with Discussion(8)

Presenter: Ariel Duran

October 22, 2012

Presentation TCT 2012

Current Landscape: One-Year Post-Initial FDA Approval

Presenter: Susheel Kodali

October 22, 2012

Advertisement

Slides

Fiberoptic Cardioscopy for Use in Epicardial Injection of Cell Suspensions and Biomaterials

Stent Thrombosis Meta-analysis

Aortic Stenosis Diagnostic and Therapeutic Clinical Pearls: A Selective View from the Guidelines (and Beyond): What Is KNOWN!

Step 3: Intellectual Property

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Exciting Cardiovascular Device Innovation from Europe: From Balloons to Stents to Closure Devices and More

Case Presentation with Discussion(8)

Current Landscape: One-Year Post-Initial FDA Approval

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content